Founded in 2006, eLumindata opened its doors to address a universal problem: most organizations struggle to extract actionable insights from their data. From the start, our mission was to revolutionize analytics so innovative companies could use data to unlock valuable business insights.
For nearly two decades, we've invested millions in developing proprietary AI technology that eliminates manual, time-consuming data processes, automatically organizing, cleansing, and preparing data for analysis. This allows our clients to focus on what truly matters: the discovery of hidden patterns and trends that create significant competitive advantage.
We don't just provide data solutions. We deliver transformative insights that solve real business challenges, optimize operations, and unlock new growth opportunities.
Our technology is purpose-built to solve what others can't. We've earned three U.S. patents for innovations that automate the analytics bottlenecks that frustrate most teams.
Unlike traditional analytics software, our platform is built on a modern AI-driven architecture that delivers smarter insights faster, without requiring a complex setup or extensive IT support. We automatically integrate, organize, and structure data with minimal effort from your team.
The result? We've set new benchmarks in speed-to-value for data analysis. Whether it's finding trends in medical records, understanding shopper behavior, or optimizing real estate portfolios, our technology adapts, scales, and performs where others struggle.
Russell brings over 25 years of leadership in data science, analytics, and business strategy.
At Pfizer Pharmaceuticals, Russell served as VP of Business Technology & Information Science during a period where Pfizer broke most industry growth records and became a global leader in analytics and business intelligence. While at Pfizer, he built and led the management science team that won the prestigious INFORMS Prize, based on over a dozen projects with an impact measured in excess of $100 million.
Russell pioneered early AI integration in forecasting models in the 1980s and has developed breakthrough technologies and strategies with industry giants, including Microsoft, CVS, UnitedHealthcare, and Lotus.
He has served on over 20 boards and advisory panels, currently serves on the Executive Committee of the DCI Network at Harvard Medical School, and has co-authored articles in the MIT Sloan Management Review and medical informatics journals.
A regular speaker at universities throughout the U.S., Russell was selected as the lead speaker for 3 consecutive years for the Data Science program, part of the Harvard Graduate School of Arts & Sciences. Russell holds AB and SM degrees in Applied Mathematics and Economics from Harvard University.
At eLumindata, our mission is simple: to make analytics smarter, faster, and more impactful. We help organizations uncover meaningful insights that would otherwise remain hidden within complex data. Our work is guided by four core values:
We believe that great analytics don’t come from tools alone; they come from understanding how analysts work, what slows them down, and what they need to succeed. That’s why we’ve built technology that eliminates the most frustrating and time-consuming part of data science: data wrangling. Our platform automates this process, enabling users to get from data to insight with speed and confidence—on desktop or even mobile devices.
Over the years, we’ve partnered with organizations across pharmaceuticals, grocery, real estate, marketing services, and more. While their business goals vary, the challenge is the same: surface the insights that matter and empower smarter decisions.